Login / Signup

Fatal allograft mucormycosis complicating severe COVID-19 infection and bacterial pyelonephritis.

Abhilash ChandraS Namrata RaoKiran Preet Malhotra
Published in: Transplant infectious disease : an official journal of the Transplantation Society (2022)
We herein present a case of live related kidney transplant recipient who initially developed severe coronavirus (COVID-19) disease associated with E.coli related pyelonephritis and graft dysfunction, who improved over one week only to deteriorate in the second week, with fever, oligoanuria and refractory shock. A postmortem allograft biopsy revealed angioinvasive mucormycosis. With the resurgence of mucormycosis during the COVID-19 pandemic, the transplant team should add allograft mucormycosis as a rare differential for severe graft dysfunction and oligoanuria in the COVID-19-infected kidney transplant recipient.
Keyphrases
  • sars cov
  • coronavirus disease
  • early onset
  • kidney transplantation
  • oxidative stress
  • respiratory syndrome coronavirus
  • palliative care
  • clinical trial
  • ultrasound guided